ReviewFrontiers in immunology2023

Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma.

Linjun Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.